SOUTHWEST ONCOLOGY GROUP S0303 Treatment Form - Arm 2 Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer Source Form: NCI FormBuilder:


Versions (3) ▾
  1. 8/27/12
  2. 1/9/15
  3. 1/9/15
Uploaded on:

January 9, 2015

No DOI assigned. To request one please log in.
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Colorectal Cancer NCT00070122 Treatment - SOUTHWEST ONCOLOGY GROUP S0303 Treatment Form - Arm 2 - 2167010v3.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0303 Treatment Form - Arm 2
    1. No Instruction available.
Vital Status
Has the patient progressed per the definition of Section 10.0 of the protocol?
Were there any dose modifications or additions/omissions to protocol treatment
Did the patient receive Oxaliplatin this cycle?
Did the patient receive Capecitabine this cycle?
Dide the patient received G-CSF?
Ccrr Module For Southwest Oncology Group S0303 Treatment Form - Arm 2

Similar models